Norges Bank Buys New Shares in Contineum Therapeutics, Inc. (NASDAQ:CTNM)

Norges Bank purchased a new position in shares of Contineum Therapeutics, Inc. (NASDAQ:CTNM – Free Report) in the 4th quarter, HoldingsChannel.com reports. The institutional investor purchased 169,729 shares of the company’s stock, valued at approximately $2,487,000. Other hedge funds and other institutional investors have also recently modified their holdings of the company. Franklin Resources Inc. […]